The company moves a step closer towards achieving its goal of emerging as the top oncology medicine supplier from India in the ASEAN region
The strategic appointment is also critical to reinforcing Healthium’s market leadership, corporate governance and deep domain expertis
Net profit for FY23 at Rs. 140 crore as compared to Rs. 166 crore in FY22
Revenue from operations at Rs 512.81 crores registered a growth of 17% Y-o-Y for full year FY23
Company intends to increase sales in the UK to approximately 2 million Euros by focusing on seven molecules which are already registered in the country
The R&D Center significantly increases Siegfried’s R&D capacity to drive further growth
Digitization has unleashed a flood of data that presents a huge opportunity but is also overwhelming clinicians, nurses, and administrators
Enabling wireless monitoring In ambulances and homes
ProBioGen previously developed the cell line and the manufacturing process and provided the initial clinical material for ImmunOs' innovative biologic.
Bourgoin early development hub broadens offerings for oral solid dose formulations
Subscribe To Our Newsletter & Stay Updated
